Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $14,226 | $13,503 | $13,297 |
| - Cash | $1,256 | $1,715 | $1,071 | $1,180 |
| + Debt | $9,335 | $11,025 | $10,841 | $11,004 |
| Enterprise Value | – | $23,535 | $23,273 | $23,121 |
| Revenue | $4,885 | $4,792 | $4,881 | $5,085 |
| % Growth | 1.9% | -1.8% | -4% | – |
| Gross Profit | $1,242 | $1,214 | $1,184 | $1,271 |
| % Margin | 25.4% | 25.3% | 24.3% | 25% |
| EBITDA | $871 | $822 | $741 | $281 |
| % Margin | 17.8% | 17.2% | 15.2% | 5.5% |
| Net Income | $275 | $225 | $151 | $67 |
| % Margin | 5.6% | 4.7% | 3.1% | 1.3% |
| EPS Diluted | 0.47 | 0.39 | 0.26 | 0.06 |
| % Growth | 20.5% | 50% | 333.3% | – |
| Operating Cash Flow | $742 | $775 | $163 | $832 |
| Capital Expenditures | -$192 | -$154 | -$146 | -$241 |
| Free Cash Flow | $549 | $621 | $17 | $591 |